AdelineMVerticelliMD

PubMed

• 1 citations
  First-in-Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetic...
  Beth Ann Reedy, Robin O'Connor-Semmes, Kimberley Hacquoil, Peter D. Gorycki, Adeline Verticelli, Angela Molga> ;Clinical Pharmacology in Drug Development. 2021 Apr 1
• 2 citations
  First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.
  Melisa Cooper, Robin O'Connor-Semmes, Beth Ann Reedy, Kimberley Hacquoil, Peter D. Gorycki, Kristen E. Pannullo, Adeline Verticelli, Sepehr Shakib> ;Clinical Pharmacology in Drug Development. 2019 Feb 1
• 86 citations
  Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.
  Kathleen M. Weisel, Nicola Scott, Debra J. Tompson, Bartholomew J. Votta, Sujith Madhavan, Kat Povey, Allen Wolstenholme, Monica Simeoni, Todd Rudo, Lauren E. Richards...> ;Pharmacology Research & Perspectives. 2017 Dec 1
• 12 citations
  Deamidation of Polyanion‐stabilized Acidic Fibroblast Growth Factor
  David B. Volkin, Adeline M. Verticelli, Mark W. Bruner, Kimberly E. Marfia, P. K. Tsai, C. Russell Middaugh, Mohinder K. Sardana> ;Journal of Pharmaceutical Sciences. 1995 Jan 1
• Interaction of nucleotides with acidic fibroblast growth factor (FGF-1).
  Chavan, A. J., Haley, B. E., Volkin, D. B., Marfia, K. E., Verticelli, A. M., Bruner, M. W., Draper, J. P., Burke, C. J., Middaugh, C. R.> ;Biochemistry. 1994 Jun 14
• Join now to see all